Literature DB >> 24532686

Attitudes toward clinical trials among patients with sickle cell disease.

Carlton Haywood1, Sophie Lanzkron1, Marie Diener-West2, Jennifer Haythornthwaite3, John J Strouse4, Shawn Bediako5, Gladys Onojobi6, Mary Catherine Beach1.   

Abstract

Background A substantial number of planned clinical trials for sickle cell disease (SCD) have terminated early due to insufficient patient enrollment. Purpose To describe attitudes toward clinical trials among a sample of adults with SCD and identify patient-level factors associated with these attitudes. Methods Our data came from a sample (N = 291) of primarily adults with SCD participating in the Improving Patient Outcomes with Respect and Trust (IMPORT) study, which is a federally funded observational study of SCD patient experiences in seeking healthcare. Attitudes toward clinical trials were assessed using items from the Perceptions of Participation in Clinical Research instrument. Patient factors examined as potential correlates of clinical trial attitudes were demographics, disease severity, engagement in self-care, trust, healthcare experience ratings, and prior history of participation in clinical trials. Multiple regression analyses were used to identify patient-level correlates of clinical trial attitudes. Results Our sample of SCD patients expressed overwhelmingly favorable attitudes about clinical trials, with 77%-92% of our sample expressing agreement with a series of positive statements about clinical trials in general. Demographics, engagement in self-care, healthcare experience ratings, and prior trial participation each explained significant portions of the variability in clinical trial attitudes. Limitations The generalizability of our results to the entire SCD population may be of concern as the study participants were all receiving care at comprehensive sickle cell centers and already participating in clinical research. Conclusion Our results suggest that, in principle, adults with SCD enrolled in an observational study express very positive general attitudes about clinical trial participation and that specific factors attached to particular clinical trial opportunities may play a greater role in a SCD patient's decision to participate than a general unwillingness to participate.

Entities:  

Mesh:

Year:  2014        PMID: 24532686      PMCID: PMC4387103          DOI: 10.1177/1740774513519876

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  29 in total

1.  Psychometric properties of the CAHPS 1.0 survey measures. Consumer Assessment of Health Plans Study.

Authors:  R D Hays; J A Shaul; V S Williams; J S Lubalin; L D Harris-Kojetin; S F Sweeny; P D Cleary
Journal:  Med Care       Date:  1999-03       Impact factor: 2.983

2.  Clinical research trials: a comparison of African Americans who have and have not participated.

Authors:  Betty M Kennedy; Michael F Burnett
Journal:  J Cult Divers       Date:  2002

3.  Development and testing of the health care system distrust scale.

Authors:  Abigail Rose; Nikki Peters; Judy A Shea; Katrina Armstrong
Journal:  J Gen Intern Med       Date:  2004-01       Impact factor: 5.128

4.  Clinical research trials: factors that influence and hinder participation.

Authors:  Betty M Kennedy; Michael F Burnett
Journal:  J Cult Divers       Date:  2007

5.  Parental attitudes toward research participation in pediatric sickle cell disease.

Authors:  Robert I Liem; Allison H Cole; Stephanie A Pelligra; Maryann Mason; Alexis A Thompson
Journal:  Pediatr Blood Cancer       Date:  2010-07-15       Impact factor: 3.167

6.  Clinical trial implementation and recruitment: lessons learned from the early closure of a randomized clinical trial.

Authors:  Marlene H Peters-Lawrence; Margaret C Bell; Lewis L Hsu; Ifeyinwa Osunkwo; Phillip Seaman; Miren Blackwood; Edouard Guillaume; Rita Bellevue; Lakshmanan Krishnamurti; Wally R Smith; Carlton D Dampier; Caterina P Minniti
Journal:  Contemp Clin Trials       Date:  2011-12-02       Impact factor: 2.226

7.  Interpersonal processes of care in diverse populations.

Authors:  A L Stewart; A Nápoles-Springer; E J Pérez-Stable
Journal:  Milbank Q       Date:  1999       Impact factor: 4.911

Review 8.  Future directions of sickle cell disease research: the NIH perspective.

Authors:  W Keith Hoots; Susan B Shurin
Journal:  Pediatr Blood Cancer       Date:  2012-04-19       Impact factor: 3.167

9.  Recruitment of infants with sickle cell anemia to a Phase III trial: data from the BABY HUG study.

Authors:  Lynn Wynn; Scott Miller; Lane Faughnan; Zhaoyu Luo; Ellen Debenham; Lea Adix; Billie Fish; Tally Hustace; Tracy Kelly; Marylou Macdermott; Joan Marasciulo; Brenda Martin; Jennifer McDuffie; Mary Murphy; Betsy Rackoff; Caroline Reed; Phillip Seaman; Glenda Thomas; Winfred Wang
Journal:  Contemp Clin Trials       Date:  2010-08-24       Impact factor: 2.226

10.  Barriers to hematopoietic cell transplantation clinical trial participation of african american and black youth with sickle cell disease and their parents.

Authors:  Nancy A Omondi; Stacy E Stickney Ferguson; Navneet S Majhail; Ellen M Denzen; George R Buchanan; Ann E Haight; Richard J Labotka; J Douglas Rizzo; Elizabeth A Murphy
Journal:  J Pediatr Hematol Oncol       Date:  2013-05       Impact factor: 1.289

View more
  7 in total

1.  Attitudes of Patients in Developing Countries Toward Participating in Clinical Trials: A Survey of Saudi Patients Attending Primary Health Care Services.

Authors:  Lateefa O Al-Dakhil; Reem Alanazy; Rakan E AlHamad; Hazem Al-Mandeel; Abdulaziz Alobaid
Journal:  Oman Med J       Date:  2016-07

Review 2.  Editing outside the body: Ex vivo gene-modification for β-hemoglobinopathy cellular therapy.

Authors:  Tolulope O Rosanwo; Daniel E Bauer
Journal:  Mol Ther       Date:  2021-10-08       Impact factor: 11.454

3.  A community-centered approach to sickle cell disease and clinical trial participation: an evaluation of perceptions, facilitators, and barriers.

Authors:  LaTasha H Lee; LaShanta H Whisenton; Jasmine Benger; Sophie Lanzkron
Journal:  Blood Adv       Date:  2021-12-14

4.  Keys to Recruiting and Retaining Seriously Ill African Americans With Sickle Cell Disease in Longitudinal Studies: Respectful Engagement and Persistence.

Authors:  Marie L Suarez; Judith M Schlaeger; Veronica Angulo; David A Shuey; Jesus Carrasco; Keesha L Roach; Miriam O Ezenwa; Yingwei Yao; Zaijie Jim Wang; Robert E Molokie; Diana J Wilkie
Journal:  Am J Hosp Palliat Care       Date:  2019-08-08       Impact factor: 2.500

5.  A re-randomisation design for clinical trials.

Authors:  Brennan C Kahan; Andrew B Forbes; Caroline J Doré; Tim P Morris
Journal:  BMC Med Res Methodol       Date:  2015-11-05       Impact factor: 4.615

6.  Using re-randomization to increase the recruitment rate in clinical trials - an assessment of three clinical areas.

Authors:  Brennan C Kahan
Journal:  Trials       Date:  2016-12-13       Impact factor: 2.279

7.  Factors Influencing Motivation and Engagement in Mobile Health Among Patients With Sickle Cell Disease in Low-Prevalence, High-Income Countries: Qualitative Exploration of Patient Requirements.

Authors:  David-Zacharie Issom; André Henriksen; Ashenafi Zebene Woldaregay; Jessica Rochat; Christian Lovis; Gunnar Hartvigsen
Journal:  JMIR Hum Factors       Date:  2020-03-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.